Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agata Malenda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Haematology|October 14, 2019
Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphomaAgata Malenda, Agnieszka Kołkowska-Leśniak, Bartosz Puła, et al.
Journal of Clinical Medicine|July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma PatientsJoanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Statins impair glucose uptake in human cellsDominika Nowis, Agata Malenda, Karolina Furs, et al.
Blood|November 21, 2015
FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomasMaciej Szydlowski, Przemyslaw Kiliszek, Tomasz Sewastianik, et al.
Chemotherapy|November 13, 2019
Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life AnalysisDariusz Wołowiec, Agnieszka Szymczyk, Stanisław Potoczek, et al.
Neoplasia (New York, N.Y.)|May 12, 2012
Statins impair glucose uptake in tumor cellsAgata Malenda, Anna Skrobanska, Tadeusz Issat, et al.
Redox Biology|December 22, 2018
Inhibition of thioredoxin-dependent H<sub>2</sub>O<sub>2</sub> removal sensitizes malignant B-cells to pharmacological ascorbateAgnieszka Graczyk-Jarzynka, Agnieszka Goral, Angelika Muchowicz, et al.
British Journal of Haematology|April 1, 2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphomaEwa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner, et al.
Blood|August 24, 2017
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodiesMalgorzata Bobrowicz, Michal Dwojak, Beata Pyrzynska, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Haematology|October 14, 2019
Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphomaAgata Malenda, Agnieszka Kołkowska-Leśniak, Bartosz Puła, et al.
Journal of Clinical Medicine|July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma PatientsJoanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Statins impair glucose uptake in human cellsDominika Nowis, Agata Malenda, Karolina Furs, et al.
Blood|November 21, 2015
FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomasMaciej Szydlowski, Przemyslaw Kiliszek, Tomasz Sewastianik, et al.
Chemotherapy|November 13, 2019
Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life AnalysisDariusz Wołowiec, Agnieszka Szymczyk, Stanisław Potoczek, et al.
Neoplasia (New York, N.Y.)|May 12, 2012
Statins impair glucose uptake in tumor cellsAgata Malenda, Anna Skrobanska, Tadeusz Issat, et al.
Redox Biology|December 22, 2018
Inhibition of thioredoxin-dependent H<sub>2</sub>O<sub>2</sub> removal sensitizes malignant B-cells to pharmacological ascorbateAgnieszka Graczyk-Jarzynka, Agnieszka Goral, Angelika Muchowicz, et al.
British Journal of Haematology|April 1, 2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphomaEwa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner, et al.
Blood|August 24, 2017
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodiesMalgorzata Bobrowicz, Michal Dwojak, Beata Pyrzynska, et al.
Pageof 1